BIO-Key International Inc

BIO-Key International Inc (BKYI) Stock Analysis

$2.740

+0.835 (+30.48%)At close

Loading chart…
High
3.250
Open
2.710
VWAP
2.85
Volume
32.44M
Mkt Cap
2.81M
Low
2.560
Amount
92.45M
EV/EBITDA, TTM
-1.15

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

AI analysis of BIO-Key International Inc (BKYI)

Buy

BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 2.74
Low
—
Average
—
High
—

Valuation Metrics

The current forward P/E ratio for BIO-Key International Inc (BKYI) is 0.00, compared to its 5-year average forward P/E of -4.52.

Forward P/E

Fair
5Y Average P/E
-4.52
Current P/E
0.00
Overvalued
1.94
Undervalued
-10.98

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
-0.24
Current EV/EBITDA
-1.15
Overvalued
0.60
Undervalued
-1.09

Forward P/S

Fair
5Y Average P/S
0.78
Current P/S
0.39
Overvalued
1.35
Undervalued
0.21

Alphio AI Price Scenarios for BKYI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BKYI

$0.91

Scenario price

B

Base

Base · 50%BKYI

$0.79

Scenario price

B

Bear

Bear · 25%BKYI

$0.72

Scenario price

Events Timeline

2026-10-22 (ET)

05:30:00

BIO-key Selected by Middle East Government for Security Project

2026-10-13 (ET)

05:30:00

BIO-key Secures New Customer in Middle East Government Security Agency

2026-10-09 (ET)

17:30:00

Selling Stockholders Plan to Sell 1.24M Shares of Common Stock

2026-09-29 (ET)

06:30:00

BIO-key Partners with Al Majlis Group for Strategic Collaboration

2026-08-10 (ET)

05:30:00

BIO-key and Visualforma Awarded New Contract by Portuguese National Security Agency

News

BKYI FAQ — answered by Alphio AI

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.

1 analysts cover BKYI: 1 rate it Buy, 0 Hold and 0 Sell.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading